162 related articles for article (PubMed ID: 21526375)
1. Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids.
González R; Cruz A; Ferrín G; López-Cillero P; Briceño J; Gómez MA; Rufián S; Padillo J; De la Mata M; Marin JJ; Muntané J
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):740-50. PubMed ID: 21526375
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide mimics transcriptional and post-translational regulation during α-tocopherol cytoprotection against glycochenodeoxycholate-induced cell death in hepatocytes.
González R; Cruz A; Ferrín G; López-Cillero P; Fernández-Rodríguez R; Briceño J; Gómez MA; Rufián S; Mata Mde L; Martínez-Ruiz A; Marin JJ; Muntané J
J Hepatol; 2011 Jul; 55(1):133-44. PubMed ID: 21145864
[TBL] [Abstract][Full Text] [Related]
3. Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy.
Miura T; Kimura N; Yamada T; Shimizu T; Nanashima N; Yamana D; Hakamada K; Tsuchida S
J Hepatol; 2011 Aug; 55(2):407-14. PubMed ID: 21167233
[TBL] [Abstract][Full Text] [Related]
4. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.
Micheline D; Emmanuel J; Serge E
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):185-91. PubMed ID: 12187295
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.
Li T; Chiang JY
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G74-84. PubMed ID: 15331348
[TBL] [Abstract][Full Text] [Related]
6. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
7. Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.
Zhou L; Pang X; Jiang J; Zhong D; Chen X
Drug Metab Dispos; 2017 May; 45(5):441-448. PubMed ID: 28202577
[TBL] [Abstract][Full Text] [Related]
8. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
[TBL] [Abstract][Full Text] [Related]
9. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
Gartung C; Matern S
Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.
Kolouchova G; Brcakova E; Hirsova P; Sispera L; Tomsik P; Cermanova J; Hyspler R; Slanarova M; Fuksa L; Lotkova H; Micuda S
J Gastroenterol Hepatol; 2011 Oct; 26(10):1544-51. PubMed ID: 21501227
[TBL] [Abstract][Full Text] [Related]
11. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis.
Zollner G; Wagner M; Fickert P; Silbert D; Gumhold J; Zatloukal K; Denk H; Trauner M
Liver Int; 2007 Sep; 27(7):920-9. PubMed ID: 17696930
[TBL] [Abstract][Full Text] [Related]
12. Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide (ntcp) in the fetal and neonatal rat liver.
Arrese M; Trauner M; Ananthanarayanan M; Boyer JL; Suchy FJ
Hepatology; 1998 Sep; 28(3):789-95. PubMed ID: 9731574
[TBL] [Abstract][Full Text] [Related]
13. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
Schoemaker MH; Gommans WM; Conde de la Rosa L; Homan M; Klok P; Trautwein C; van Goor H; Poelstra K; Haisma HJ; Jansen PL; Moshage H
J Hepatol; 2003 Aug; 39(2):153-61. PubMed ID: 12873810
[TBL] [Abstract][Full Text] [Related]
14. Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.
Feng XC; Du X; Chen S; Yue D; Cheng Y; Zhang L; Gao Y; Li S; Chen L; Peng Z; Yang Y; Luo W; Wang R; Chen W; Chai J
Int J Clin Exp Pathol; 2015; 8(1):184-95. PubMed ID: 25755705
[TBL] [Abstract][Full Text] [Related]
15. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes.
Danchenko E; Petermann H; Chirkin A; Dargel R
Exp Toxicol Pathol; 2001 Jun; 53(2-3):227-33. PubMed ID: 11484843
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidants do not prevent bile acid-induced cell death in rat hepatocytes.
Woudenberg-Vrenken TE; Buist-Homan M; Conde de la Rosa L; Faber KN; Moshage H
Liver Int; 2010 Nov; 30(10):1511-21. PubMed ID: 20825559
[TBL] [Abstract][Full Text] [Related]
17. Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver.
Sanoh S; Tamura Y; Fujino C; Sugahara G; Yoshizane Y; Yanagi A; Kisoh K; Ishida Y; Tateno C; Ohta S; Kotake Y
Biol Pharm Bull; 2019; 42(8):1366-1375. PubMed ID: 31366871
[TBL] [Abstract][Full Text] [Related]
18. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
[TBL] [Abstract][Full Text] [Related]
19. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
Ogimura E; Sekine S; Horie T
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
[TBL] [Abstract][Full Text] [Related]
20. Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.
Mizuochi T; Kimura A; Tanaka A; Muto A; Nittono H; Seki Y; Takahashi T; Kurosawa T; Kage M; Takikawa H; Matsuishi T
Clin Chim Acta; 2012 Aug; 413(15-16):1301-4. PubMed ID: 22525741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
